Obesity Managements Market: Industry Analysis, Opportunity and Forecast to 2030
The obesity management market size is projected to expand at 9.20% CAGR to
reach USD 268.7 billion during the forecast period 2022-2030.
According to World Health Organization (WHO), the
worldwide prevalence of obesity nearly doubled between 1980 and 2008. According
to country estimates for 2008, over 50% of both men and women in the WHO
European Region were overweight, and roughly 23% of women and 20% of men were
obese. It is the cause of many health problems, such as obesity, heart disease,
and certain cancers. Obesity leads to short- and long-term health problems for
mother and her child, if she is excess weight during pregnancy.
Companies are continuously engaged in research and
development process along with well know research institute for developing the
best treatment of obesity and leads the market. In 2015, researchers at the
University of Liverpool, working with a global health care company, have helped
introduce a new treatment for obesity. After conducting the research it was
found that the treatment which is a once-daily injectable derivative of a
metabolic hormone called GLP-1 normally used in the type 2 obesity
treatment, has proved that it help non diabetic patients in
weight loss. These development help company to provide the best option for the
treatment and capture the maximum share of global market.
Major Key Players:
Pfizer Inc. (U.S.), Merck
Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), F.
Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), AstraZeneca
plc (U.K), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)
are some of the Obesity Management Market
Players, globally.
Segmental
Overview
The segmental analysis of
the global obesity management market has been conducted on the basis of
prescription, surgery and lifestyle changes.
Based on prescription, the
market has been segmented into lorcaserin (Belviq), buproprion and naltrexone
(Contrave), liraglutide (Saxenda), orlistat (Xenical), phentermine and
topiramate (Qsymia) and others. Based on surgery, the market has been segmented
into Biliopancreatic diversion with duodenal switch, Laparoscopic adjustable
gastric banding (LAGB), Gastric bypass
surgery and others. Based on lifestyle changes, the market has been segmented
into exercise, dietary changes and others.
Regional
Analysis
The market of obesity management is
growing rapidly in Asia Pacific region, owing to poor diet, lack of physical
activity, and unhealthy life balance. These are the factor which leads the
obesity population in this region. Most of the countries of this region have
common lifestyle and economic conditions, So the factor introduce above have
common with in this region and leads the patient population. Government of
developing countries within this region are more focusing towards new
technology and advance treatment option, thus more research and development
programs are initiated for the development of new drugs. These are the
factors which are fuelling the growth of the market of obesity managements with
the significant rates. These advance treatment will overcome the saturation that
occurs during last few years. Countries like India and china are more focused
market for global market players owing to huge patient population and growing
purchasing power as compare to other countries in this region. The market of
obesity management is much higher in the Americas region attribute to high
presence of obesity population along with developed treatment option. According
to CDC, 37.9% of adults over 20 years were suffering with the obesity between
2013 and 2014 and 70.7% of adults aged 20 years and over were suffering with
overweight, including obesity. These stats show the opportunity of market
players within the Americas region.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment